# FDA recall D-1518-2016

> **Genzyme Corporation / Genzyme Biosurgery** · Class III · drug recall initiated 2016-08-04.

## Product

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by:  Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp. Date

## Distribution

nationwide

## Key facts

- **Recall number:** D-1518-2016
- **Recalling firm:** Genzyme Corporation / Genzyme Biosurgery
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-08-04
- **Report date:** 2016-09-28
- **Termination date:** 2018-04-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ridgefield, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1518-2016

## Citation

> AI Analytics. FDA recall D-1518-2016. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1518-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*